heptapeptide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-05-19 and is reviewed periodically as new material appears.
Semax is a synthetic heptapeptide developed in the Soviet Union during the 1980s by researchers at the Institute of Molecular Genetics in Moscow. It was designed as a truncated analog of adrenocorticotropic hormone, retaining only the fragment spanning residues four through ten. Investigators sought a peptide that would preserve the cognitive effects associated with ACTH while eliminating the hormonal stimulation of the adrenal cortex. The compound entered clinical use in Russia during the following decade.
Russian regulatory authorities approved the peptide for nasal administration, and it remains listed in the national pharmacopoeia under several trade names. Documented indications include acute ischemic stroke, transient ischemic attacks, traumatic brain injury, and certain ophthalmological and neurological conditions. Physicians also prescribe it for cognitive complaints in older patients, although the evidence base for that use is thinner. Outside Russia and a few neighboring states, the substance is not an approved medicine and is sold instead as a research chemical.
Semax is normally supplied as a lyophilized powder, and that form is the most stable. Suppliers commonly recommend storage at -20 °C in a desiccated container protected from light, with short-term handling at room temperature limited to weighing and transfer. Powder that has absorbed moisture degrades faster, so vials should be warmed to ambient temperature before opening to prevent condensation on the contents. Hygroscopic behavior is typical of short hydrophilic peptides, and humidity control matters more than temperature alone for long-term retention.
Once dissolved, the peptide is considerably less stable than the solid. Aqueous solutions are usually prepared at neutral to slightly acidic pH, filtered, and divided into single-use aliquots before freezing. Repeated freeze-thaw cycles are a common cause of avoidable loss and are best prevented by never refreezing a thawed aliquot. Adsorption to plastic and glass surfaces can lower the measured concentration of dilute solutions, particularly below roughly 0.1 mg/mL. Buffer choice, salt content, and container material all influence how much peptide remains detectable after storage.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic heptapeptide | Analog of an ACTH fragment |
| Amino acid length | Seven residues | Met-Glu-His-Phe-Pro-Gly-Pro |
| Origin | Moscow, 1980s | Institute of Molecular Genetics |
| Approved regions | Russia and some neighboring states | Not cleared in Western markets |
| Common trade names | Multiple national brands | Sold as a nasal formulation |
Clinical reports describe use in ischaemic stroke, transient ischaemic attack, optic nerve conditions, and cognitive complaints, but most of these studies are small and were conducted in a single region. Systematic reviews have generally described the evidence base as limited in size and variable in methodological quality. Randomised controlled data suitable for international regulatory assessment are scarce. As a result, major treatment guidelines outside Russia do not include the peptide, and interest in it remains largely research-driven rather than routine clinical.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is described in the literature as an analogue of the ACTH(4–10) fragment, a short N-terminal portion of adrenocorticotropic hormone that retains some neurotropic activity without the full hormonal effects of the parent peptide. The molecule carries a methionine residue at the N-terminus and two proline residues near the C-terminus, features that shape both its interactions with receptor systems and its chemical stability. The free peptide corresponds to the formula C37H51N9O10S and a molecular mass near 813.9 Da.
Published studies examine a fairly narrow set of endpoints. Rodent experiments commonly measure maze learning, infarct volume after induced ischemia, and tissue levels of neurotrophic factors. Clinical reports from Russian centres describe attention, memory and recovery scores in patients after stroke or transient ischemic attack. Most of those human studies are small and few have been repeated by independent groups. Outcome measures differ between studies, which limits direct comparison.
Circulation time for the peptide is short because peptidases cleave it readily. The Pro-Gly-Pro tail is thought to slow breakdown compared with the bare ACTH fragment, but the gain appears modest. Absorption after intranasal dosing is limited, and only a fraction of a dose is expected to reach the central nervous system. Laboratory concentrations therefore sit well above levels achieved systemically, a gap that complicates translation from bench findings to clinical claims.
{\displaystyle G^{*}+M\to M^{+\bullet }+e^{-}+G} where G is the excited state species (indicated by the superscripted asterisk), and M is the species that is ionized by the loss of an electron to form the radical cation (indicated by the superscripted "plus-dot"). Penning ionization refers to the interaction between a gas-phase excited-state atom or molecule G* and a target molecule M resulting in the formation of a radical molecular cation M+., an electron e−, and a neutral gas molecule G: G ∗ + M → M + ∙ + e − + G {\displaystyle G^{*}+M\to M^{+\bullet }+e^{-}+G} Penning ionization occurs when the target molecule has an ionization potential lower than the internal energy of the excited-state atom or molecule. Associative Penning ionization can also occur: G ∗ + M → M G + ∙ + e − {\displaystyle G^{*}+M\to MG^{+\bullet }+e^{-}} There are many important dissociation reactions that take place in the gas phase.
=== Early assumptions === From the 1860s through 1871, early forms of the periodic table proposed by Dmitri Mendeleev contained a gap between molybdenum (element 42) and ruthenium (element 44). In 1871, Mendeleev predicted this missing element would occupy the empty place below manganese and have similar chemical properties. Mendeleev gave it the provisional name eka-manganese (from eka, the Sanskrit word for one) because it was one place down from the known element manganese.
== Pharmacokinetics == The absolute bioavailability of lobeglitazone is about 95% in rat. In human, the mean steady state clearance (CLss/F) was 1.13 L/h across in 1 to 4 mg dose range. In the dose range, the mean half-life was 10.3 h. Urine excretion was negligible amount in elimination of lobeglitazone in rat and human. The plasma protein binding of the drug is over 99%. The average blood-to-plasma concentration ratio was 0.636. The unbound fraction of lobeglitazone in microsomal incubation medium was 0.479. Lobeglitazone was primarily distributed to the liver with tissue-to-plasma concentration ratio as 5.59, and less to heart, lung, and fat. The tissue to plasma concentration ratios were ranged from about 0.25 to 4.0 for major tissues, in rat. Among six major membrane transporters recommended by the United States Food and Drug Administration, lobeglitazone interacts with OATP1B1, OAT3, and MDR1. In vitro, lobeglitazone was a substrate of rodent OATP1B2. Lobeglitazone interacted with CYP1A2, 2C9 and 2C19. Distribution to liver of lobeglitazone was inhibited by atorvastatin, in rats.
Sources: en.wikipedia.org
==== Diabetes ==== A meta-analysis reported that vitamin D supplementation significantly reduced the risk of type 2 diabetes for non-obese people with prediabetes. Another meta-analysis reported that vitamin D supplementation significantly improved glycemic control [homeostatic model assessment-insulin resistance (HOMA-IR)], hemoglobin A1C (HbA1C), and fasting blood glucose (FBG) in individuals with type 2 diabetes. In prospective studies, high versus low levels of vitamin D were respectively associated with a significant decrease in risk of type 2 diabetes, combined type 2 diabetes and prediabetes, and prediabetes. A systematic review included one clinical trial that showed vitamin D supplementation together with insulin maintained levels of fasting C-peptide after 12 months better than insulin alone.
=== War on cartels (2025–present) === The war on cartels is a hybridization of the war on terror and the war on drugs that describes the most aggressive and militarized phase of US foreign and security policy toward transnational criminal organizations, particularly active beginning in 2025 and into early 2026. Some analysts have noted that this war is moving away from previous paradigms of the war on drugs to become an official war. Unlike the law enforcement–centered efforts of previous decades, this phase is characterized by treating drug cartels not merely as ordinary criminal groups, but as national security threats equivalent to insurgent or terrorist organizations, thereby authorizing the use of high-level military capabilities. As a result, this strategy represents an operational and legal hybridization, as it merges the core objective of the war on drugs—the interdiction of narcotics flows and the dismantling of illicit economies—with the combat doctrine of the war on terror, shifting the paradigm from civilian law enforcement toward military counterinsurgency. By classifying these organizations as existential threats and narcoterrorist entities, the US legitimizes the use of tools traditionally reserved for enemy combatants, such as drone strikes, offensive cyber warfare, and extraterritorial special operations, including Operation Southern Spear, under the premise that cartels are no longer simple criminal groups to be arrested, but rather paramilitary structures that erode state sovereignty and require an asymmetric warfare response to be neutralized.
== Chronometry == Determining a nuclear material's age is critical to nuclear forensic investigations. Dating techniques can be utilized to identify a material's source as well as procedures performed on the material. This can aid in determining the information about the potential participant in the "age" of the material of interest. Nuclides, related through radioactive decay processes will have relative sample concentrations that can be predicted using parent-daughter in-growth equations and relevant half-lives. Because radioactive isotopes decay at a rate determined by the amount of the isotope in a sample and the half-life of the parent isotope, the relative amount of the decay products compared to the parent isotopes can be used to determine "age". Heavy element nuclides have a 4n+2 relationship, where the mass number divided by 4 leaves a remainder of two. The decay network begins with 238Pu and proceeds through the in-growth of long-lived 234U, 230Th, and 226Ra. If any member of the 4n+2 decay chain is purified it will immediately begin to produce descendant species. The time since a sample was last purified can be calculated from the ratio of any two concentrations among the decaying nuclides. Essentially, if a nuclear material has been put through a refinement process to remove the daughter species, the time elapsed since purification can be "back-calculated" using radiochemical separation techniques in conjunction with analytical measurement of the existing parent-daughter ratios.
Sources: en.wikipedia.org
It originated at the Institute of Molecular Genetics in Moscow during the 1980s. The work was carried out by a Russian research group that specialized in peptide neuropharmacology.
It is registered as a medicine in Russia and has been used clinically there for decades. No regulatory agency in Western Europe or North America has approved it for any indication.
Semax corresponds to the four-to-ten fragment of adrenocorticotropic hormone. Because it omits the first three residues, it lacks the adrenal-stimulating action of the full hormone.
Each freeze-thaw cycle can degrade a fraction of the peptide and promote aggregation. Dividing a stock solution into single-use volumes removes repeated cycling as a variable. It also limits the time a thawed solution spends at room temperature.